© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Alzheimer's Association International Conference
Marwan Sabbagh, MD: Observations From AAIC 2020
September 01, 2020
The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic detailed the state of Alzheimer disease and what research particularly grabbed his attention at AAIC 2020.
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care
August 12, 2020
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Q&A: Genetic Ancestry and Alzheimer Disease Risk
August 06, 2020
Katrina Celis, MD, a postdoctoral fellow at the University of Miami Miller School of Medicine, discussed how ancestral genetics can play a key role in Alzheimer disease risk.
Sargramostim Shows Safety and Promise as Potential Alzheimer Treatment
August 06, 2020
The investigators wrote that the Alzheimer’s Association “Part the Cloud” funded 24-week treatment trial is now warranted after sargramostim showed a safe and tolerable profile.
Dementia-Related Psychosis Places Heavy Burden on Patients and Caretakers
August 05, 2020
Data from 2 posters presented at AAIC 2020 suggest that there is an unmet need for safe and effective treatments for patients who experience dementia-related psychosis.
Raymond S. Turner, MD, PhD: Safety Results for Nilotinib in Alzheimer
August 05, 2020
The director of the Memory Disorders Program and professor of neurology at Georgetown University Medical Center detailed the phase 2 study findings of nilotinib in patients with Alzheimer disease.
12 Modifiable Risk Factors to Reduce Dementia Risk
August 03, 2020
Excessive alcohol intake, head injury, and air pollution are among the newest dementia risk factors added to the Lancet Commission report.
Nilotinib Safety Profile Sets Agent Up For Phase 3 Study
August 01, 2020
The director of the Memory Disorders Program and professor of neurology at Georgetown University Medical Center details his findings from the phase 2 study of nilotinib in patients with Alzheimer disease.
Katrina Celis, MD: Ancestral Genetics and the Impact on Alzheimer Disease Risk
August 01, 2020
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed her study presented at AAIC 2020 that examined Alzheimer risk associated with APOE ε4 in different genetic populations.
Hypertension, Diabetes, High BMI All Early Life Risk Factors for Dementia
July 30, 2020
Multiple studies presented at AAIC 2020 highlight and confirm previous hypotheses of the role that early life cardiovascular risk factors play for individuals who develop late life dementia.